Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Total 13F shares
-
152,837,109
-
Share change
-
-4,493,290
-
Total reported value
-
$2,291,153,384
-
Put/Call ratio
-
86%
-
Price per share
-
$14.99
-
Number of holders
-
157
-
Value change
-
-$72,488,750
-
Number of buys
-
71
-
Number of sells
-
64
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q4 2017
As of 31 Dec 2017 IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) had 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 152,837,109 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, BlackRock Inc., Vanguard Group Inc, JANUS HENDERSON GROUP PLC, UBS ASSET MANAGEMENT AMERICAS INC, BROWN CAPITAL MANAGEMENT LLC, EcoR1 Capital, LLC, and STATE STREET CORP.
This table shows 157 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.